Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2007 1
2008 1
2009 1
2010 1
2011 3
2012 3
2014 3
2015 2
2016 3
2018 1
2019 4
2020 2
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer.
Camisaschi C, Vallacchi V, Vergani E, Tazzari M, Ferro S, Tuccitto A, Kuchuk O, Shahaj E, Sulsenti R, Castelli C, Rodolfo M, Rivoltini L, Huber V. Camisaschi C, et al. Vaccines (Basel). 2016 Nov 4;4(4):38. doi: 10.3390/vaccines4040038. Vaccines (Basel). 2016. PMID: 27827921 Free PMC article. Review.
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015.
Nanda VGY, Peng W, Hwu P, Davies MA, Ciliberto G, Fattore L, Malpicci D, Aurisicchio L, Ascierto PA, Croce CM, Mancini R, Spranger S, Gajewski TF, Wang Y, Ferrone S, Vanpouille-Box C, Wennerberg E, Pilones KA, Formenti SC, Demaria S, Tang H, Wang Y, Fu YX, Dummer R, Puzanov I, Tarhini A, Chauvin JM, Pagliano O, Fourcade J, Sun Z, Wang H, Sanders C, Kirkwood JM, Chen THT, Maurer M, Korman AJ, Zarour HM, Stroncek DF, Huber V, Rivoltini L, Thurin M, Rau T, Lugli A, Pagès F, Camarero J, Sancho A, Jommi C, de Coaña YP, Wolodarski M, Yoshimoto Y, Gentilcore G, Poschke I, Masucci GV, Hansson J, Kiessling R, Scognamiglio G, Sabbatino F, Marino FZ, Anniciello AM, Cantile M, Cerrone M, Scala S, D’alterio C, Ianaro A, Cirin G, Liguori G, Bott G, Chapman PB, Robert C, Larkin J, Haanen JB, Ribas A, Hogg D, Hamid O, Testori A, Lorigan P, Sosman JA, Flaherty KT, Yue H, Coleman S, Caro I, Hauschild A, McArthur GA, Sznol M, Callahan MK, Kluger H, Postow MA, Gordan R, Segal NH, Rizvi NA, Lesokhin A, Atkins MB, Burke MM, Ralabate A, Rivera A, Kronenberg SA, Agunwamba B, Ruisi M, Horak C, Jiang J, Wolchok J, Ascierto PA, Liszkay G, Maio M, Mandalà M, Demidov L, Stoyakovskiy D, Thomas L, de la Cruz-Me… See abstract for full author list ➔ Nanda VGY, et al. J Transl Med. 2016 Jul 25;14(1):65. doi: 10.1186/s12967-016-0791-2. J Transl Med. 2016. PMID: 27461275 Free PMC article.
Ascierto, Emilia Caputo P2 Anti-proliferative and pro-apoptotic effect of ABT888 on melanoma cell lines and its potential role in the treatment of melanoma resistant to B-RAF inhibitors Federica Fratangelo, Rosa Camerlingo, Emilia Caputo, Maria Letizia Motti, Rosaria Falcone, Rob …
Ascierto, Emilia Caputo P2 Anti-proliferative and pro-apoptotic effect of ABT888 on melanoma cell lines and its potential role in the treatm …
Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.
Johnson RW, Alvarez-Pasquin MJ, Bijl M, Franco E, Gaillat J, Clara JG, Labetoulle M, Michel JP, Naldi L, Sanmarti LS, Weinke T. Johnson RW, et al. Ther Adv Vaccines. 2015 Jul;3(4):109-20. doi: 10.1177/2051013615599151. Ther Adv Vaccines. 2015. PMID: 26478818 Free PMC article. Review.
This is an overview of the multidisciplinary implications and management of HZ in which the potential contribution of vaccination to reducing the incidence HZ and its complications are also discussed....
This is an overview of the multidisciplinary implications and management of HZ in which the potential contribution of vaccination to …
Subacute cutaneous lupus erythematosus induced by Pfizer COVID-19 vaccine.
Magnaterra E, Magliulo M, Mariotti EB, Ruffo DI Calabria V, Quintarelli L, Corrà A, Aimo C, Verdelli A, Caproni M. Magnaterra E, et al. Ital J Dermatol Venerol. 2023 Jun;158(3):266-267. doi: 10.23736/S2784-8671.23.07373-5. Epub 2023 Mar 7. Ital J Dermatol Venerol. 2023. PMID: 36881332 No abstract available.
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients.
Schiaroli E, Gidari A, Brachelente G, Bicchieraro G, Spaccapelo R, Bastianelli S, Pierucci S, Busti C, Pallotto C, Malincarne L, Camilloni B, Falcinelli F, De Socio GV, Villa A, Mencacci A, Francisci D. Schiaroli E, et al. J Clin Virol. 2023 Nov;168:105584. doi: 10.1016/j.jcv.2023.105584. Epub 2023 Sep 17. J Clin Virol. 2023. PMID: 37778220 Free article.
RESULTS: At baseline, 35.2%, 37.02%, and 32.5% of booster vaccinated patients exhibited undetectable levels of anti-S and anti-RBD IgG antibodies such as NT(90)-Abs titres against A20.EU1. ...Four patients (7.5%) had a severe acute respiratory syndrome coronavirus 2 (SARS- …
RESULTS: At baseline, 35.2%, 37.02%, and 32.5% of booster vaccinated patients exhibited undetectable levels of anti-S and anti-RBD Ig …
Characterization of MDCK cells and evaluation of their ability to respond to infectious and non-infectious stressors.
Capellini FM, Vencia W, Amadori M, Mignone G, Parisi E, Masiello L, Vivaldi B, Ferrari A, Razzuoli E. Capellini FM, et al. Cytotechnology. 2020 Feb;72(1):97-109. doi: 10.1007/s10616-019-00360-z. Epub 2019 Dec 4. Cytotechnology. 2020. PMID: 31802289 Free PMC article.
The Madin-Darby Canine Kidney (MDCK) cell line is widely used as epithelial cell model in studies ranging from viral infection to environmental pollutants, and vaccines production. However, little is known about basal expression of genes involved in innate immunity, and th …
The Madin-Darby Canine Kidney (MDCK) cell line is widely used as epithelial cell model in studies ranging from viral infection to environmen …
Hepatitis A: Epidemiology and prevention in developing countries.
Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Franco E, et al. World J Hepatol. 2012 Mar 27;4(3):68-73. doi: 10.4254/wjh.v4.i3.68. World J Hepatol. 2012. PMID: 22489258 Free PMC article.
Several factors contribute to the decline of the infection rate, including rising socioeconomic levels, increased access to clean water and the availability of a hepatitis A vaccine that was developed in the 1990s. For populations with a high proportion of susceptible adul …
Several factors contribute to the decline of the infection rate, including rising socioeconomic levels, increased access to clean water and …
Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines.
Manara C, Brazzoli M, Piccioli D, Taccone M, D'Oro U, Maione D, Frigimelica E. Manara C, et al. Vaccine. 2019 Jul 9;37(30):4204-4213. doi: 10.1016/j.vaccine.2019.04.028. Epub 2019 Jun 18. Vaccine. 2019. PMID: 31227353
Recent published data support the hypothesis that Antigen Presenting Cells (APCs) are responsible for CD8+ T-cell priming after SAM vaccination, suggesting cross-priming as the key mechanism for antigen presentation by SAM vaccines. ...In conclusion, we demonstrated …
Recent published data support the hypothesis that Antigen Presenting Cells (APCs) are responsible for CD8+ T-cell priming after SAM vacci …
31 results